BIRC5 and hepatocellular carcinoma: (13) revealed that survivin, as a member of the inhibitor of apoptosis protein (IAP) family, is highly expressed in HCC, and its overexpression can promote cancer cell proliferation, inhibit cancer cell apoptosis, reduce the sensitivity of cancer cells to radiotherapy and chemotherapy, and ultimately affect the prognosis of patients with HCC.